In 2016, Jeffrey Topfer founded Shifox Corporation, also known as Alopex, with a vision for transforming healthcare. Grounded in reality yet driven by optimism, Jeffrey sought to improve physicians' job satisfaction and enhance patient care. His journey in healthcare began in the early 1990s when he co-founded a physician management company during the rise of the HMO industry. He became a trailblazer in healthcare partnerships, advisory services, and innovative approaches to clinician, payor, and supplier relationships.

By the early 2000s, Jeffrey revolutionized clinician note-taking with a transcription service that integrated cutting-edge technology, further demonstrating his ability to anticipate and respond to the evolving needs of the healthcare industry. Throughout his career, he continuously refined healthcare delivery systems into solution-oriented programs, prioritizing secure data management and impactful solutions.

Alopex became the culmination of Jeffrey's dedication to innovation and his commitment to improving the quality of life for physicians. He worked tirelessly on every aspect of the company, from operations to development, embodying the qualities of a hands-on leader with an unwavering focus on customer satisfaction.

Beyond his professional achievements, Jeffrey excelled at building and fostering relationships. As a tenured healthcare executive and lobbyist, he possessed a genuine interest in people, forming lasting bonds that shaped both his business and personal life. These values established the foundation for Alopex’s culture. Jeffrey believed in the power of human connection, and this belief influenced every iteration of his work—from improving patients' lives through his products to uniting clinicians with transformative technology.

Jeffrey’s unwavering pride in his team was evident, and he remained confident in their ability to carry his vision forward. His dedication to understanding patient needs and fostering meaningful partnerships continues to drive Alopex’s mission.

Tragically, Jeffrey passed away on October 5, 2024. His legacy of innovation, leadership, and compassion will live on in Alopex and the countless lives he impacted. For those wishing to honor his memory, we encourage contributions to the Pancreatic Cancer Action Network, an advocacy and research organization dedicated to advancing cancer research and supporting patients: Pancreatic Cancer Action Network – Research, Patient Support, Resources.

Jeffrey Topfer’s passion for people, healthcare, and innovation will forever inspire the work we do at Alopex. His vision remains the guiding light for the future of the company he so deeply cared about.